肺血管扩张剂药物不良反应与肺动脉高压患者临床预后的关系

发布时间：2018-04-30 22:20

  本文选题：肺血管扩张剂 + 肺动脉高压　； 参考：《中华高血压杂志》2017年04期

【摘要】：正肺动脉高压(pulmonary arterial hypertension,PAH)患者使用肺血管扩张剂发生药物不良反应(adverse drug events,ADEs)很常见。ADEs可能导致生活质量下降;然而,它们与预后的关系未知。该研究的目的是确定开始皮下曲前列环素治疗后常见的ADEs是否与PAH的预后相关。方法:纳入来自4个PAH曲前列环素临床试验的受试者进行回顾性队列研究,其中
[Abstract]:Adverse drug reactions with pulmonary vasodilator may lead to a decline in quality of life (QOL) in patients with pulmonary arterial hypertensioning. However, the relationship between ADEs and prognosis is unknown. The aim of this study was to determine whether common ADEs after subcutaneous triprostacyclin therapy was associated with the prognosis of PAH. Methods: a retrospective cohort study was conducted in four subjects from four PAH triprostacyclin clinical trials.
【分类号】：R544.1
，

本文编号：1826489